About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5708 record(s)
Req # A-2023-000589
All notes made by the Health Canada employees who reviewed the Pfizer-BioNTech Comirnaty COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.Organization: Health Canada
March 2024
Req # A-2023-000605
All notes made by the Health Canada employees who reviewed the Novavax Nuvaxovid COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2020 to December 31, 2020.Organization: Health Canada
March 2024
Req # A-2023-000619
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practice (GMP) inspection of the Novo Nordisk Canada facility (Site A) on Argentina Rd, Mississauga, Ontario, starting around 03/20/2019.Organization: Health Canada
March 2024
Req # A-2023-000639
With respect to generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient mesalazine, any document that would indicate the current status of the submission.Organization: Health Canada
March 2024
Req # A-2023-000664
In 2021 an Advance Contract Award Notice (ACAN), Number 1000230021 was issued by Health Canada in relation to a contract with Georgetown University Medical Centre. The analysis conducted on the updated model.Organization: Health Canada
March 2024
Req # A-2023-000678
Any records on Wunnumin Lake Diesel Generating System, Wunnumin Lake, Ontario.Organization: Health Canada
March 2024
Req # A-2023-000679
Records on Muskrat Dam First Nation, Muskrat Dam Diesel Generating Station or Muskrat Dam Water Treatment System.Organization: Health Canada
March 2024
Req # A-2023-000746
Inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practice (GMP) inspection of Baxter (Site A) on Centre St S, Alliston, Ontario starting around 27 September 2021. Reference Number 505702.Organization: Health Canada
March 2024
Req # A-2023-000832
The number of people employed by your department who have had contract service recognized since 1989 and any employment benefits they may have received, indicating the years of service, monetary value of benefits and the financial authority under which any payments were made.Organization: Health Canada
March 2024
Req # A-2023-001002
The month and year that the Rupatadine Abbreviated New Drug Submission (ANDS) was accepted into review; and the status of the ANDS review for the Rupatadine ANDS.Organization: Health Canada
March 2024